Enanta Pharmaceuticals | 债务利息支出





债务利息支出 更改 日
AbbVie USD 740M 40M 2025-06
Amgen USD 653M 32M 2025-12
Anika Therapeutics 189.44M 1.76M 2025-09
Arrowhead Research USD 22.5M 811K 2025-12
AstraZeneca USD 484M 181M 2025-12
BioCryst Pharmaceuticals USD 24.45M 381K 2024-12
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 432M 48M 2025-12
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Gilead Sciences USD 256M 2M 2025-09
GlaxoSmithKline GBP 188M 21M 2025-12
Halozyme Therapeutics USD 4.3M 98K 2025-09
Heron Therapeutics USD 500K 900K 2024-09
Immunic 400K 400K 2024-12
Incyte USD 582K 10K 2025-12
Insmed USD 20.38M 863K 2025-09
Ionis Pharmaceuticals USD 18M 1000K 2025-09
J&J USD 18M 290M 2025-09
Karyopharm Therapeutics USD 11.38M 2.43M 2024-09
Ligand Pharmaceuticals USD 910K 243K 2025-09
Merck USD 412M 85M 2025-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 281M 8M 2025-09
Novavax USD 4.24M 96K 2024-09
Pfizer USD 711M 59M 2025-12
PTC Therapeutics USD 2.64B 2.61B 2025-09
Roche Holding CHF 304M 7.5M 2025-06
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
Vertex Pharmaceuticals USD 3.3M 400K 2025-09


Enanta Pharmaceuticals 债务利息支出 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.